Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)
Clinical trial NCT01148511 · COMPLETED
Trial details
- NCT number
- NCT01148511
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-04-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.